Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Consumables segment develops and sells scientific materials, such as nucleic acid purification; and designs and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. Stratec SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+49-7082-79160
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$187.82 million
Profitability
Miscellaneous
Employees1,158
Next Earnings Date5/24/2019 (Estimated)
OptionableOptionable
Stratec (ETR:SBS) Frequently Asked Questions
What is Stratec's stock symbol?
Stratec trades on the ETR under the ticker symbol "SBS."
When is Stratec's next earnings date?
What price target have analysts set for SBS?
3 Wall Street analysts have issued 12-month price objectives for Stratec's shares. Their predictions range from €55.00 to €81.00. On average, they anticipate Stratec's share price to reach €70.33 in the next year. This suggests a possible upside of 8.2% from the stock's current price. View Analyst Price Targets for Stratec.
What is the consensus analysts' recommendation for Stratec?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stratec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stratec.
Has Stratec been receiving favorable news coverage?
Headlines about SBS stock have trended somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stratec earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term.
Who are some of Stratec's key competitors?
Some companies that are related to Stratec include ConvaTec Group (CTEC), Inspire Medical Systems (INSP), Draegerwerk AG & Co KGaA (DRW3), Avita Medical (AVH), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Titan Medical (TMD), Advanced Oncotherapy (AVO), Cyclopharm (CYC), Impedimed (IPD), Helius Medical Technologies (HSM), Kromek Group (KMK), REVA Medical (RVA) and Osprey Medical (OSP).
What other stocks do shareholders of Stratec own?
Who are Stratec's key executives?
Stratec's management team includes the folowing people:
- Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 52)
- Dr. Robert Siegle, Director of Fin. & HR and Member of Board of Management (Age 52)
- Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 52)
- Mr. Hermann Leistner, Founder & Advisor (Age 73)
- Sandra Eberle, Head of Investor Relations
What is Stratec's stock price today?
One share of SBS stock can currently be purchased for approximately €65.00.
How big of a company is Stratec?
Stratec has a market capitalization of $777.17 million and generates $187.82 million in revenue each year. Stratec employs 1,158 workers across the globe.
What is Stratec's official website?
How can I contact Stratec?
Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160.
MarketBeat Community Rating for Stratec (ETR SBS)
MarketBeat's community ratings are surveys of what our community members think about Stratec and other stocks. Vote "Outperform" if you believe SBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days.
